Cytek Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
Cytek Biosciences; flow cytometry; access expansion; ISAC collaboration; instrument awards; research grants; Full Spectrum Profiling (FSP); European expansion; Amsterdam facility; cell analysis
United Imaging Healthcare Q3 2025 Results: Overseas Revenue Up 42% YoY
United Imaging Healthcare; Q3 2025 results; overseas revenue growth; medical imaging; emerging markets; R&D investment; global expansion
Vistagen Appoints Paul Edick to its Board of Directors
Vistagen; Paul Edick; Board of Directors; Audit Committee; Compensation Committee; Biopharmaceutical; Pharmaceutical industry; Corporate governance
Astellas Pharma Revises Financial Forecasts for FY2025
Astellas; Financial Forecast Revision; FY2025; Revenue Upgrade; Operating Profit; Pharmaceutical Industry; Strategic Brands; Pipeline Progress; SG&A Optimization
GSK Trims Pipeline and Upgrades Guidance in Emma Walmsley’s Last Earnings Report
GSK; pipeline reduction; earnings; Emma Walmsley; Q3 2025; guidance upgrade; Specialty Medicines; operating profit; dividend; R&D progress
BioMarin Plans to Divest Hemophilia Gene Therapy Roctavian Amid Strategic Refocus
BioMarin; Roctavian; hemophilia A; gene therapy; divestment; out-licensing; portfolio strategy; third quarter 2025; revenue challenge
Eli Lilly and Nvidia to Build Pharma’s Largest AI Supercomputer for Drug Discovery
Eli Lilly; Nvidia; supercomputer; AI; drug discovery; Blackwell Ultra GPU; clinical trials; biomedical foundation models; pharmaceutical industry; high-performance computing
No Recent News on BridgeBio’s Thyroid Disorder Phase 3 Win
BridgeBio; Phase 3; Rare Diseases; Thyroid Disorder
Step Pharma Appoints Dr. Karen L. Smith as Chief Medical Officer
Step Pharma; Karen Smith; Chief Medical Officer; CTPS1 inhibitor; dencatistat; oncology; clinical development; biopharmaceutical; regulatory affairs
Jazz Pharmaceuticals Appoints Dr. Ted Love to Board of Directors
Jazz Pharmaceuticals; Ted Love; Board appointment; Board of Directors; Corporate governance; Audit Committee; Science and Medicine Committee; Kenneth W. O’Keefe retirement